Trial record 10 of 246 for:
Open Studies | "Glaucoma"
Contrast Sensitivity in Glaucoma
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by University of Erlangen-Nürnberg Medical School.
Recruitment status was Recruiting
Information provided by:
University of Erlangen-Nürnberg Medical School
First received: July 27, 2009
Last updated: NA
Last verified: July 2009
History: No changes posted
The primary aim of the Erlangen´s Glaucoma Contrast Sensitivity-Study (EGCS-Study) is the evaluation of the diagnostic and prognostic validity of a diagnostic procedure, measuring contrast sensitivity. No therapeutic studies are performed.
Primary Open Angle Glaucoma
Secondary Open Angle Glaucoma Due to PEX
||Observational Model: Cohort
Time Perspective: Prospective
||Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)
| Estimated Enrollment:
| Study Start Date:
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Patients: Primary open angle glaucoma, secondary open angle glaucoma due to PEX
- Healthy volunteers (for reliability analysis)
- Age > 18
- Best corrected visual acuity 0.8 or better
- eye diseases: Infantile glaucoma, angle glaucoma, secondary open angle glaucoma, wich are not due to PEX, diseases involving retina, condition after ophthalmological operations or trauma, cataract, diseases concerning the refractive system, age-related macular degeneration, diabetic retinopathy, optic neuropathy (MS, neuritis), amblyopia
- Any neurological diseases
- Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)
- Systemic drugs with potentially ocular involvement
- ocular drugs
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00947869
|University Eye Hospital
|Erlangen, Bavaria, Germany, 91054 |
|Contact: Hohberger **49-9131-8534521 |
University of Erlangen-Nürnberg
||Anselm G Juenemann, Prof.
No publications provided
||University Eye Hospital Erlangen, University of Erlangen-Nürnberg
History of Changes
|Other Study ID Numbers:
|Study First Received:
||July 27, 2009
||July 27, 2009
||Germany: Ethics Commission
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on September 18, 2014